$21.530
+0.041 (+0.19%)收盘时
价格预测
在 App 中打开以解锁更长周期的预测。
DAWN 相似图表分析预测
Alphio's DAWN stock price prediction model matches the current Day One Biopharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $21.51 (-0.09%). The 1-week path is $21.79 (+1.22%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
该买入 Day One Biopharmaceuticals Inc 股票吗？
Day One Biopharmaceuticals Inc (DAWN) is not a good buy for a beginner, long-term investor at this time. The stock is being acquired by Servier at a fixed price of $21.50 per share, which limits any upside potential. The acquisition has already been finalized, and the stock price is trading at the acquisition price, leaving no room for growth or significant returns.
DAWN 股价于 Wednesday 收于 $21.53，此前上涨 +0.19%
Day One Biopharmaceuticals Inc (DAWN) last closed at $21.53, gaining +0.19%. These facts feed the 1-day and 1-week DAWN price prediction above.
预测驱动因素
Day One Biopharmaceuticals Inc（DAWN）的预测驱动因素综合了相似的图表形态、季节性与移动平均线。
Similar patterns
Bearish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bullish
相似图表形态
近期走势与 DAWN 最接近的股票，按相似度排序。
DAWN 季节性分析
Historically the probability of a positive August return for DAWN is 0.00%. February offers the highest probability of a positive month at 65.52%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。